logo
logo

Foresite Capital Raises $173 Million To Fund Foresite Labs Incubated Life Science Companies

Mar 03, 2022•over 3 years ago

Amount Raised

$173 Million

San Francisco

Description

Foresite Capital, a multi-stage healthcare and life sciences investment firm, today announced it has raised a $173 million fund to further invest in companies launched by Foresite Labs. Foresite Labs companies will also continue to be supported from Foresite Capital Fund V and its associated opportunities fund. The fund comes on the heels of several major milestones for Foresite Capital including the announcement of its $969 million Fund V and investments in Foresite Labs incubated companies Interline Therapeutics, Alumis and TenSixteen Bio.

Company Information

Company

Foresite Capital

Location

San Francisco, California, United States

About

Foresite Capital is a multi-stage healthcare and life sciences investment firm with approximately $4 billion in assets under management. The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Founded in 2011, Foresite Capital is based in the San Francisco Bay Area and New York City. For more information, please visit www.foresitecapital.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People